Red De Terapia Celular
🇪🇸Spain
- Country
- 🇪🇸Spain
- Ownership
- Private
- Established
- 2006-01-01
- Employees
- 251
- Market Cap
- -
- Website
- https://www.red-tercel.com
Clinical Trials
17
Active:0
Completed:12
Trial Phases
2 Phases
Phase 1:13
Phase 2:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (17 trials with phase data)• Click on a phase to view related trials
Phase 1
13 (76.5%)Phase 2
4 (23.5%)Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stem Cells
Phase 2
Completed
- Conditions
- COVID-19 Pneumonia
- First Posted Date
- 2020-04-24
- Last Posted Date
- 2024-02-02
- Lead Sponsor
- Red de Terapia Celular
- Target Recruit Count
- 24
- Registration Number
- NCT04361942
- Locations
- 🇪🇸
Hospital Universitario Rio Hortega, Valladolid, Spain
Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells
Phase 2
Recruiting
- Conditions
- Lupus NephritisLupus Erythematosus
- Interventions
- Drug: Mesenchymal stem cells (MSC)Drug: Placebo
- First Posted Date
- 2018-09-17
- Last Posted Date
- 2025-07-24
- Lead Sponsor
- Red de Terapia Celular
- Target Recruit Count
- 20
- Registration Number
- NCT03673748
- Locations
- 🇪🇸
University Hospital Río Hortega, Valladolid, Spain
Clinical Trial of Use of Autologous Bone Marrow Stem Cells Seeded on Porous Tricalcium Phosphate Matrix and Demineralized Bone Matrix in Patients With Osteonecrosis
Phase 1
- Conditions
- Osteonecrosis of Jaw
- First Posted Date
- 2015-10-02
- Last Posted Date
- 2017-03-30
- Lead Sponsor
- Red de Terapia Celular
- Target Recruit Count
- 10
- Registration Number
- NCT02566681
- Locations
- 🇪🇸
Hospital Clínico Virgen de la Arrixaca, El Palmar, Murcia, Spain
Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis
Phase 1
Completed
- Conditions
- OsteoporosisSpinal Fractures
- First Posted Date
- 2015-10-02
- Last Posted Date
- 2020-10-08
- Lead Sponsor
- Red de Terapia Celular
- Target Recruit Count
- 10
- Registration Number
- NCT02566655
- Locations
- 🇪🇸
Hospital Clínico Virgen de la Arrixaca, El Palmar, Murcia, Spain
Lumbar Degenerative Disc Disease Treatment With Bone Marrow Autologous Mesenchymal Stem Cells (MSV)
Phase 1
Withdrawn
- Conditions
- Degenerative Disc Disease
- First Posted Date
- 2015-05-12
- Last Posted Date
- 2015-05-12
- Lead Sponsor
- Red de Terapia Celular
- Registration Number
- NCT02440074
- Prev
- 1
- 2
- 3
- 4
- Next
News
No news found